Nephros Inc
Research Nephros Inc (NEPH) on Bullrun: market cap USD 38.77M, P/E 22.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNEPH
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 38.77M
- P/E22.8
- Financial periodQ2 2026
- RevenueUSD 6.02M
- Net incomeUSD 1.20M
- Free cash flowUSD 681.00K
- Gross margin66.9%
Valuation Snapshot
latest market cap is USD 38.77M; P/E is 22.8.
Peer valuation comparison
Latest P/E is 22.83x versus a Healthcare sector median of 24.6x (7.2% below).
Latest P/E is 22.83x versus a United States median of 23.85x (4.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 18.79M | USD 1.19M | USD 1.65M | 61.9% | 0.11 | USD 5.40M | USD 1.06M | USD 10.20M |
| FY2024 | USD 14.16M | USD 74.00K | -USD 547.00K | 61.6% | 0.01 | USD 3.76M | USD 1.41M | USD 8.59M |
| FY2023 | USD 14.24M | -USD 1.58M | USD 752.00K | 59.0% | -0.15 | USD 4.31M | USD 1.84M | USD 8.36M |
| FY2022 | USD 9.98M | -USD 7.11M | -USD 3.37M | 47.4% | -0.73 | USD 3.63M | USD 71.00K | USD 5.59M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 38.77M | 22.8 | n/a | n/a |
| 2025 | 2025-12-31 | USD 51.94M | 44.4 | n/a | n/a |
| 2024 | 2024-12-31 | USD 15.50M | 147.0 | n/a | n/a |
| 2023 | 2023-12-29 | USD 36.28M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 11.97M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 60.52M | n/a | n/a | n/a |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nephros Inc's market cap?
Nephros Inc's market capitalization is USD 38.77M.
What is Nephros Inc's P/E ratio?
Nephros Inc's price-to-earnings (P/E) ratio is 22.8.
What does Nephros Inc do?
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.